scholarly article | Q13442814 |
P356 | DOI | 10.1002/JNR.10139 |
P698 | PubMed publication ID | 11835313 |
P2093 | author name string | Guy Weinberg | |
Douglas L Feinstein | |||
Michael T Heneka | |||
Aigang Lu | |||
Frank R Sharp | |||
Cinzia Dello Russo | |||
Patricia Murphy | |||
Anthony Sharp | |||
Vitaliy Gavrilyuk | |||
Joseph Shin | |||
P2860 | cites work | Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation | Q24564127 |
Non-steroidal anti-inflammatory drugs inhibit the expression of cytokines and induce HSP70 in human monocytes | Q28162595 | ||
Herbimycin, a new antibiotic produced by a strain of Streptomyces | Q28327610 | ||
Inhibitory and stimulatory effects of lactacystin on expression of nitric oxide synthase type 2 in brain glial cells. The role of Ikappa B-beta | Q28569263 | ||
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids | Q29616817 | ||
Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. | Q32049448 | ||
HSP90 interacts with and regulates the activity of heat shock factor 1 in Xenopus oocytes | Q33776598 | ||
Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity | Q33888219 | ||
Cell mediators of inflammation in the Alzheimer disease brain | Q33941244 | ||
Series introduction: the transcription factor NF-kappaB and human disease | Q34116362 | ||
Interleukin 1 in the brain: biology, pathology and therapeutic target | Q34117586 | ||
NF-kappaB in neuronal plasticity and neurodegenerative disorders | Q34131754 | ||
I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations | Q34179362 | ||
Role of nuclear factor kappa B in neuropathological mechanisms | Q34361301 | ||
Immunological aspects of microglia: relevance to Alzheimer's disease | Q34386107 | ||
Cloning and expression of inducible nitric oxide synthase from rat astrocytes. | Q36674680 | ||
Phenotypic change from transformed to normal induced by benzoquinonoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus | Q36915975 | ||
Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. | Q37302901 | ||
Mechanism of quercetin-induced suppression and delay of heat shock gene expression and thermotolerance development in HT-29 cells | Q38305122 | ||
Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages | Q40786648 | ||
Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships | Q40935078 | ||
Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts. Evidence for increased cell viability and suppression of cytokine release | Q41010028 | ||
Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin | Q41168181 | ||
The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin | Q42826312 | ||
Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds | Q45307438 | ||
Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG). | Q46595832 | ||
Suppression of glial nitric oxide synthase induction by heat shock: effects on proteolytic degradation of IkappaB-alpha. | Q47697721 | ||
Potent inhibition of inducible nitric oxide synthase by geldanamycin, a tyrosine kinase inhibitor, in endothelial, smooth muscle cells, and in rat aorta | Q48801680 | ||
The heat shock response reduces myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in mice | Q48921063 | ||
Heat shock protein 70 suppresses astroglial-inducible nitric-oxide synthase expression by decreasing NFkappaB activation | Q48960660 | ||
P433 | issue | 4 | |
P304 | page(s) | 461-470 | |
P577 | publication date | 2002-02-01 | |
P1433 | published in | Journal of Neuroscience Research | Q6295654 |
P1476 | title | Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis | |
P478 | volume | 67 |
Q40374915 | 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration |
Q39715278 | Activation of the stress protein response inhibits the STAT1 signalling pathway and iNOS function in alveolar macrophages: role of Hsp90 and Hsp70. |
Q28076199 | Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies |
Q36657652 | Autoimmune modulation of astrocyte-mediated homeostasis. |
Q44757991 | Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease |
Q39281800 | Heat shock protein 90 inhibitor attenuates renal fibrosis through degradation of transforming growth factor-β type II receptor. |
Q28300549 | Inducible heat shock protein 70 kD and inducible nitric oxide synthase in hemorrhage/resuscitation-induced injury |
Q48253153 | Interleukin-12 induces mild experimental allergic encephalomyelitis following local central nervous system injury in the Lewis rat. |
Q36495265 | Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein |
Q36759577 | Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy. |
Q44478728 | Physical activity alters the brain Hsp72 and IL-1beta responses to peripheral E. coli challenge |
Q27000682 | Positive or negative involvement of heat shock proteins in multiple sclerosis pathogenesis: an overview |
Q92553022 | Regional differences in the inflammatory and heat shock response in glia: implications for ALS |
Q37010253 | The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE. |
Q33531705 | To fold or not to fold: modulation and consequences of Hsp90 inhibition |
Search more.